• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Evaluation of in vitro activity of teicoplanin against recent clinical isolates.

作者信息

Nani E, Amato G, Anzivino D, Covelli B, Lembo M

机构信息

Department of Cellular and Molecular Biology and Pathology, II Medical School, University of Naples, Italy.

出版信息

Chemioterapia. 1988 Feb;7(1):20-3.

PMID:2967737
Abstract

The in vitro antibacterial activity of teicoplanin, a new glycopeptide antibiotic, previously named teichomycin A2, has been compared to that of five other chemoantibiotics: netilmicin, clindamycin, rifampicin, enoxacin and vancomycin. The minimum inhibitory concentration (MIC) values against 588 gram-positive strains, 561 facultative aerobes and 27 anaerobes, recently isolated from clinical specimens, were evaluated. Teicoplanin showed the highest activity against all the tested strains, with a geometrical mean of the MICs (GMM), a MIC50 and MIC90 of 0.123, 0.12 and 0.5 micrograms/ml respectively.

摘要

相似文献

1
Evaluation of in vitro activity of teicoplanin against recent clinical isolates.
Chemioterapia. 1988 Feb;7(1):20-3.
2
Microbiological profile of teicoplanin.
J Chemother. 1991 Jan;3 Suppl 1:39-42.
3
Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci.替考拉宁与万古霉素对革兰氏阳性球菌的体外抗菌活性比较。
Drugs Exp Clin Res. 1987;13(4):225-9.
4
In vitro activity of vancomycin and teicoplanin against anaerobic bacteria.万古霉素和替考拉宁对厌氧菌的体外活性。
Drugs Exp Clin Res. 1987;13(9):551-4.
5
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates.达巴万星对6000多株临床分离株的活性和抗菌谱的全球评估。
Diagn Microbiol Infect Dis. 2004 Feb;48(2):137-43. doi: 10.1016/j.diagmicrobio.2003.09.004.
6
In vitro activities of dalbavancin and 12 other agents against 329 aerobic and anaerobic gram-positive isolates recovered from diabetic foot infections.达巴万星及其他12种药物对从糖尿病足感染中分离出的329株需氧和厌氧革兰氏阳性菌的体外活性。
Antimicrob Agents Chemother. 2006 Aug;50(8):2875-9. doi: 10.1128/AAC.00286-06.
7
Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres.达巴万星对来自拉丁美洲医疗中心的革兰氏阳性临床分离株的抗菌活性。
Clin Microbiol Infect. 2005 Feb;11(2):95-100. doi: 10.1111/j.1469-0691.2004.01051.x.
8
Comparative in vitro activities of XRP 2868, pristinamycin, quinupristin-dalfopristin, vancomycin, daptomycin, linezolid, clarithromycin, telithromycin, clindamycin, and ampicillin against anaerobic gram-positive species, actinomycetes, and lactobacilli.XRP 2868、原始霉素、奎奴普丁-达福普汀、万古霉素、达托霉素、利奈唑胺、克拉霉素、替利霉素、克林霉素和氨苄西林对厌氧革兰氏阳性菌、放线菌和乳酸杆菌的体外活性比较
Antimicrob Agents Chemother. 2005 Jan;49(1):408-13. doi: 10.1128/AAC.49.1.408-413.2005.
9
In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteria.
Drugs Exp Clin Res. 1987;13(8):479-81.
10
Evaluation of in vitro activity of teicoplanin against gram-positive anaerobic bacteria.替考拉宁对革兰氏阳性厌氧菌的体外活性评估。
J Chemother. 1989 Jul;1(4 Suppl):201-2.

引用本文的文献

1
Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.替考拉宁:抗菌活性、药代动力学特性及治疗潜力综述
Drugs. 1990 Sep;40(3):449-86. doi: 10.2165/00003495-199040030-00007.